198 related articles for article (PubMed ID: 28565842)
1. Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing.
Qiang R; Cai N; Wang X; Wang L; Cui K; Wang W; Wang X; Li X
Exp Ther Med; 2017 May; 13(5):2304-2310. PubMed ID: 28565842
[TBL] [Abstract][Full Text] [Related]
2. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective analysis of 44 578 pregnancies undergoing non-invasive prenatal testing in Weifang].
Xu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1065-1068. PubMed ID: 32924102
[TBL] [Abstract][Full Text] [Related]
4. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China.
Liu S; Chang Q; Yang F; Xu Y; Jia B; Wu R; Li L; Yin A; Chen W; Huang F; Yang X; Li F
Arch Gynecol Obstet; 2023 Sep; 308(3):787-795. PubMed ID: 36602559
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases.
Zhang Y; Xu H; Zhang W; Liu K
Front Genet; 2022; 13():864076. PubMed ID: 36186462
[No Abstract] [Full Text] [Related]
7. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China.
Xiang L; Zhu J; Deng K; Li Q; Tao J; Li M; Wang Y; Yuan X; Yao Y; Li X
Prenat Diagn; 2023 Jul; 43(8):1036-1043. PubMed ID: 36639250
[TBL] [Abstract][Full Text] [Related]
9. The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton: a retrospective study.
Yuan X; Yong W; Dai L; Wang W; Wu L
Ann Transl Med; 2023 Jan; 11(2):111. PubMed ID: 36819517
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China.
Lu W; Huang T; Wang XR; Zhou JH; Yuan HZ; Yang Y; Huang TT; Liu DP; Liu YQ
J Assist Reprod Genet; 2020 Dec; 37(12):3143-3150. PubMed ID: 33094428
[TBL] [Abstract][Full Text] [Related]
11. Performance of Momguard, a new non-invasive prenatal testing protocol developed in Korea.
Lee MY; Cho DY; Won HS; Hwang AR; Jeong B; Kim J; Oh M
Obstet Gynecol Sci; 2015 Sep; 58(5):340-5. PubMed ID: 26430657
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies.
Xue Y; Zhao G; Li H; Zhang Q; Lu J; Yu B; Wang T
Mol Cytogenet; 2019; 12():29. PubMed ID: 31249627
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
Manotaya S; Xu H; Uerpairojkit B; Chen F; Charoenvidhya D; Liu H; Petcharaburanin N; Liu Y; Tang S; Wang X; Dansakul S; Thomsopa T; Gao Y; Zhang H; Xu H; Jiang H
Prenat Diagn; 2016 Mar; 36(3):224-31. PubMed ID: 26748603
[TBL] [Abstract][Full Text] [Related]
14. Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies.
Baranova EE; Sagaydak OV; Galaktionova AM; Kuznetsova ES; Kaplanova MT; Makarova MV; Belenikin MS; Olenev AS; Songolova EN
BMC Pregnancy Childbirth; 2022 Aug; 22(1):633. PubMed ID: 35945516
[TBL] [Abstract][Full Text] [Related]
15. Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran.
Garshasbi M; Wang Y; Hantoosh Zadeh S; Giti S; Piri S; Reza Hekmat M
Fetal Diagn Ther; 2020; 47(3):220-227. PubMed ID: 31487708
[TBL] [Abstract][Full Text] [Related]
16. Association of maternal risk factors with fetal aneuploidy and the accuracy of prenatal aneuploidy screening: a correlation analysis based on 12,186 karyotype reports.
Wei L; Zhang J; Shi N; Luo C; Bo L; Lu X; Gao S; Mao C
BMC Pregnancy Childbirth; 2023 Mar; 23(1):136. PubMed ID: 36864406
[TBL] [Abstract][Full Text] [Related]
17. Application of non-invasive prenatal testing to 91,280 spontaneous pregnancies and 3477 pregnancies conceived by in vitro fertilization.
Wei R; Li J; Xia Y; Wang C; Lu X; Fang Y; Zhu J
Mol Cytogenet; 2023 Sep; 16(1):25. PubMed ID: 37726793
[TBL] [Abstract][Full Text] [Related]
18. A dPCR-NIPT assay for detections of trisomies 21, 18 and 13 in a single-tube reaction-could it replace serum biochemical tests as a primary maternal plasma screening tool?
Dai P; Yang Y; Zhao G; Gu Z; Ren H; Hu S; Liu N; Jiao W; Li J; Kong X
J Transl Med; 2022 Jun; 20(1):269. PubMed ID: 35706031
[TBL] [Abstract][Full Text] [Related]
19. [Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples].
Li Z; Duan H; Liu W; Zhu R; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):1-7. PubMed ID: 38171551
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
